Parametric Portfolio Associates’s GenMark Diagnostics, Inc GNMK Stock Holding History

Parametric Portfolio Associates’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-43,480	Closed	-$1.04M	–	3636
2021 Q1	$1.04M	Sell	43,480 -81,052	-65%	-$1.51M	﹤0.01%	3147
2020 Q4	$1.82M	Sell	124,532 -6,620	-5%	-$87.7K	﹤0.01%	2714
2020 Q3	$1.86M	Sell	131,152 -68,218	-34%	-$1.04M	﹤0.01%	2546
2020 Q2	$2.93M	Buy	+199,370	New	+$2.03M	﹤0.01%	2247
2020 Q1	–	Sell	-15,674	Closed	-$75K	–	4045
2019 Q4	$75K	Buy	15,674 +1,825	+13%	+$10.1K	﹤0.01%	3897
2019 Q3	$84K	Buy	+13,849	New	+$86.4K	﹤0.01%	3857
2018 Q4	–	Sell	-27,153	Closed	-$200K	–	3999
2018 Q3	$200K	Buy	27,153 +146	+0.5%	+$1.07K	﹤0.01%	3764
2018 Q2	$172K	Buy	27,007 +2,999	+12%	+$19.8K	﹤0.01%	3727
2018 Q1	$131K	Buy	24,008 +10,496	+78%	+$52.2K	﹤0.01%	3823
2017 Q4	$56K	Buy	+13,512	New	+$81.3K	﹤0.01%	3863

Parametric Portfolio Associates's GNMK Position: Q2 2021 in Review

Parametric Portfolio Associates sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 43,480 shares — an estimated $1.04M sold.

Parametric Portfolio Associates first reported a position in GNMK in Q4 2017 and held it in 10 quarters. The position peaked at $2.93M in Q2 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Parametric Portfolio Associates reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Parametric Portfolio Associates sold 43,480 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $1.04M.
Parametric Portfolio Associates first reported a position in GenMark Diagnostics, Inc in Q4 2017 and held it in 10 quarters.
Parametric Portfolio Associates's GenMark Diagnostics, Inc position peaked at $2.93M in Q2 2020.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Parametric Portfolio Associates's 13F filing for Q2 2021, filed 13 Aug 2021.